Touvay C, Pfister A, Vilain B, Carré C, Page C P, Lellouch-Tubiana A, Pignol B, Mencia-Huerta J M, Braquet P
Institut Henri Beaufour, Les Ulis, France.
Pulm Pharmacol. 1991;4(1):43-51. doi: 10.1016/0952-0600(91)90038-5.
The effect of chronic administration of platelet-activating factor (PAF) on airway reactivity, cell recruitment and lung morphology in the guinea-pig has been investigated. Alzet osmotic minipumps delivering either PAF (7.2 mg/kg/14 days) in 0.25% (w/v) bovine serum albumin in saline (saline-BSA), acetylcholine or saline-BSA alone were implanted s.c. in the neck region of guinea-pigs and connected to the jugular vein. In some experiments, implanted and non-implanted animals were treated daily with the PAF antagonist, BN 52021 (15 mg/kg, twice a day, p.o.). On day 15 after minipump implantation, the animals were anesthetized with urethane (1.2 g/kg, i.p.) and tracheal cannula was inserted for mechanical ventilation. Pulmonary inflation pressure (PIP) was monitored and airway responsiveness was assessed by administration of increasing doses of histamine (0.2-100 micrograms/kg, i.v.). As compared to saline-BSA-treated or non-implanted guinea-pigs, chronic treatment of the animals with PAF induced a significant (p less than 0.01) increase in airway response. No significant change in airway responsiveness was observed following chronic acetylcholine administration. In contrast, regardless of the treatment of the animals, no change in the threshold dose of histamine inducing alteration in PIP was noted, suggesting that PAF induces bronchopulmonary hyperreactivity rather than hyperresponsiveness. In addition, no significant difference was observed in the in vitro responsiveness to histamine of lung parenchymal strips from animals having received PAF or saline-BSA.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了长期给予血小板活化因子(PAF)对豚鼠气道反应性、细胞募集和肺形态的影响。将Alzet渗透微型泵皮下植入豚鼠颈部区域,该微型泵可输送溶解于含0.25%(w/v)牛血清白蛋白的生理盐水中(生理盐水-牛血清白蛋白)的PAF(7.2mg/kg/14天)、乙酰胆碱或仅输送生理盐水-牛血清白蛋白,并与颈静脉相连。在一些实验中,对植入和未植入微型泵的动物每天口服PAF拮抗剂BN 52021(15mg/kg,每日两次)。微型泵植入后第15天,用乌拉坦(1.2g/kg,腹腔注射)麻醉动物,并插入气管插管进行机械通气。监测肺膨胀压(PIP),并通过静脉注射递增剂量的组胺(0.2 - 100μg/kg)评估气道反应性。与生理盐水-牛血清白蛋白处理组或未植入微型泵的豚鼠相比,用PAF长期处理动物可导致气道反应性显著(p < 0.01)增加。长期给予乙酰胆碱后未观察到气道反应性有显著变化。相反,无论动物接受何种处理,诱导PIP改变的组胺阈值剂量均未观察到变化,这表明PAF诱导的是支气管肺高反应性而非高敏感性。此外,在接受PAF或生理盐水-牛血清白蛋白的动物的肺实质条带对组胺的体外反应性方面未观察到显著差异。(摘要截短至250字)